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ABSTRACT 1 
 2 
Purpose 3 
Individuals of African descent (AFD) are more susceptible to non-freezing cold 4 
injury than Caucasians (CAU) which may be due, in part, to differences in the 5 
control of skin blood flow. We investigated the skin blood flow responses to 6 
transdermal application of vasoactive agents.  7 
  8 
Methods 9 
Twenty four young males (12 CAU and 12 AFD) undertook three tests in which 10 
iontophoresis was used to apply acetylcholine (ACh 1 w/v %), sodium 11 
nitroprusside (SNP 0.01 w/v %) and noradrenaline (NA 0.5 mM) to the skin. The 12 
skin sites tested were: volar forearm, non-glabrous finger and toe, and glabrous 13 
finger (pad) and toe (pad). 14 
  15 
Results 16 
In response to SNP on the forearm, AFD had less vasodilatation for a given 17 
current application than CAU (P = 0.027 to 0.004). ACh evoked less 18 
vasodilatation in AFD for a given application current in the non-glabrous finger 19 
and toe compared with CAU (P = 0.043 to 0.014) with a lower maximum 20 
vasodilatation in the non-glabrous finger (Median [interquartile], AFD n=11, 21 
41[234]%, CAU n=12, 351[451]%, P = 0.011) and non-glabrous toe (Median 22 
[interquartile], AFD n=9, 116[318]%, CAU n=12, 484[720]%, P = 0.018). ACh 23 
and SNP did not elicit vasodilatation in the glabrous skin sites of either group. 24 
There were no ethnic differences in response to NA.  25 
 26 
Conclusion 27 
AFD have an attenuated endothelium-dependent vasodilatation in non-glabrous 28 
sites of the fingers and toes compared with CAU. This may contribute to lower 29 
skin temperature following cold exposure and the increased risk of cold injuries 30 
experienced by AFD. 31 
  32 
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INTRODUCTION 1 
 2 
The feet and hands of individuals who experience local cold tissue 3 
temperatures (0 °C to 20 °C) for prolonged periods are at risk of non-freezing 4 
cold injury (NFCI) (Ungley and Blackwood 1942). Although the feet are at the 5 
greatest risk of suffering a NFCI, various peripheral regions including hand, face 6 
and ears are also susceptible (Ungley et al. 1945). Daanen and van der Struijs 7 
(2005) showed that out of 57 individuals who suffered a NFCI during winter 8 
military operations, 72 % occurred in the feet, 25 % in the hands with the 9 
remaining injuries occurring on the head. In the UK military, the proportion of 10 
patients seen with NFCI of the hands was 41 % in 2007 seen by the Institute of 11 
Naval Medicine’s Cold Injury Clinic (Oakley 2009). Symptoms of this injury may 12 
last for many years and often include pain, numbness and hyperhidrosis which, 13 
combined with cold hypersensitivity of the injured limb, can lead to increased 14 
susceptibility to further cold injuries (Ungley et al. 1945; Golden et al. 2013). 15 
This type of injury is a concern for those involved in fishery and agricultural 16 
work, military operations as well as those participating recreational activities in 17 
the cold (e.g. skiing, mountaineering) (Hashmi et al. 1998; Mäkinen et al. 2009; 18 
Russell et al. 2013). Additionally, NFCI has come close to deciding the outcome 19 
of military conflicts (Golden et al. 2013) and has had financial implications in the 20 
form of occupational claims for compensation. 21 
 22 
There are various predisposing factors for cold injuries, these include: high 23 
altitude (Hashmi et al. 1998); age (> 62 years) (Koutsavlis and Kosatsky 2003; 24 
Sawada 2005); gender (females) (Army Medical Surveillance Activity 2013), 25 
nicotine (Cleophas et al. 1982; Waeber et al. 1984) and caffeine consumption 26 
(Kim et al. 2013). Ethnicity is also a risk factor; individuals of black African 27 
descent (AFD) are more susceptible than Caucasian (CAU) individuals to NFCI 28 
(Miller and Bjornson 1962; Taylor 1992; Candler and Ivey 1997; Conway and 29 
Husberg 1999; DeGroot et al. 2003; Burgess and Macfarlane 2009). It is 30 
thought that sustained skin blood flow in the extremities in low environmental 31 
temperatures can prevent local cold injuries such as NFCI (Lewis 1930; Wilson 32 
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and Goldman 1970; Daanen and van der Struijs 2005). We have previously 1 
observed that during hand immersion in cold water (8 °C) for 30 minutes and 2 
subsequent rewarming of dry skin in 30 °C air, AFD experience greater 3 
vasoconstriction and also rewarm later and more slowly than CAU (Maley et al. 4 
2014). Furthermore, during hand and forearm cooling and rewarming the onset 5 
of finger vasoconstriction and vasodilatation occurs at a warmer skin 6 
temperature in AFD compared with CAU, resulting in a greater ‘dose of cold’ 7 
(Maley et al. 2014).  8 
 9 
Taken together, it appears that the greater susceptibility of AFD to NFCI may be 10 
due to differences in the control of skin blood flow between these two ethnic 11 
groups. It is important to investigate both glabrous and non-glabrous extremity 12 
skin sites as NFCI occurs at both sites, but the control of skin blood flow 13 
appears to differ between these sites. The control of skin blood flow is intricate. 14 
Sympathetic vasoconstrictor and vasodilator nerves innervate all areas of non-15 
glabrous (hairy) skin, whereas glabrous (hairless) skin is thought to be 16 
innervated solely by vasoconstrictor nerves (Sarnoff and Simeone 1947; 17 
Johnson et al. 1995) although this has been contested (Lundberg et al. 1989). 18 
An important feature of the control of skin blood flow in glabrous skin is the 19 
existence of arteriovenous anastomoses (AVA), which are thick muscular, low 20 
resistance vessels that allow high flow rates directly from arterioles to venules 21 
(Grant 1930; Grant and Bland 1931; Clark 1938). Glabrous regions, such as the 22 
finger tips, have up to 236 AVA per cm2, whereas no AVA are found in non-23 
glabrous regions of the hand or foot, or the volar surface of the forearm (Grant 24 
and Bland 1931).  25 
 26 
The control of skin blood flow has been examined using agents that influence 27 
endothelium-dependent or independent vasodilatation, as well as 28 
vasoconstriction. Previous investigations have reported that AFD experience an 29 
attenuated response to endothelium-dependent vasodilators (e.g. methacholine 30 
or acetylcholine) compared with CAU in the forearm circulation (Stein et al. 31 
1997; Jones et al. 1999) although this was not supported by Kahn et al. (2002). 32 
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Blood flow responses to an endothelium-independent vasodilator (e.g. sodium 1 
nitroprusside or glyceryltrinitrate) appears to be mixed with some observations 2 
showing similar responses between AFD and CAU (Kahn et al. 2002; Melikian 3 
et al. 2007), whilst others have shown a lower blood flow response in AFD 4 
compared with CAU (Stein et al. 1997; Cardillo et al. 1999). The vascular 5 
responses to vasoconstrictor agents (e.g. angiotensin II or phenylephrine) has 6 
not been as extensively studied, but responses may (Stein et al. 2000), or may 7 
not (Jones et al. 1999), differ between ethnic groups.  8 
 9 
The skin blood flow responses to local application of vasoactive agents in CAU 10 
and AFD in skin sites susceptible to NFCI are not known. Therefore, the aim of 11 
the present study was to examine endothelium-dependent and independent 12 
dilatation by using acetylcholine (ACh) and sodium nitroprusside (SNP), 13 
respectively. We also investigated any potential vasoconstrictor differences by 14 
utilising noradrenaline (NA). Both non-glabrous and glabrous skin sites on the 15 
fingers and toes as well as the forearm were tested. It was hypothesised that 16 
AFD would experience an attenuated response to ACh and SNP and an 17 
exaggerated response to NA compared with CAU. 18 
 19 
METHODS 20 
 21 
Participants 22 
 23 
12 CAU and 12 AFD male volunteers participated in the study. All participants 24 
were non-smokers, were free from any vascular or blood disorders including 25 
hypertension, sickle cell disease, diabetes and Raynaud's phenomenon, with no 26 
history of either freezing or non-freezing cold injuries. Participants’ history of 27 
cold exposure was ascertained by questionnaire with each ethnic group 28 
reporting similar exposure to cold. Ethnicity was determined by self-29 
classification and all participants were UK residents at the time of testing. All 30 
CAU were born in the UK. Four AFD participants were born in the UK whilst 31 
eight had resided in the UK for an average of six years; four were born in 32 
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Zimbabwe, two were born in Nigeria, one was born in Ghana and one was born 1 
in Italy. Prior to testing, participants were asked to refrain from consuming 2 
alcohol for 24 hours and participating in exercise or consuming caffeine for 12 3 
hours.  4 
 5 
Experimental procedures and measurements 6 
 7 
Participants attended the laboratory on three occasions separated by at least 24 8 
hours where they received local transdermal application of either ACh, SNP or 9 
NA using iontophoresis in a balanced order. The technique of iontophoresis has 10 
been described previously (Morris and Shore 1996; Roustit et al. 2014). Briefly, 11 
iontophoresis is a non-invasive method of transdermal drug delivery which 12 
transfers charged molecules using a low-intensity electric current into and 13 
through the skin to a depth of approximately 2 to 4 mm (Anderson et al. 2003). 14 
 15 
All experiments were carried out in a quiet temperature controlled chamber. 16 
Environmental (dry bulb) temperature was maintained at 23 °C for ACh and 17 
SNP protocols. The NA protocol was conducted at a (dry bulb) temperature of 18 
24 °C. Pilot testing demonstrated that participants at rest in these environmental 19 
temperatures were within the “vasomotor zone” (i.e. neither fully 20 
vasoconstricted nor vasodilated) and provided the ideal baseline to observe 21 
vasodilatation and vasoconstriction respectively. Each participant was supine 22 
throughout the experiment. Blood pressure, from the contralateral arm used for 23 
iontophoresis, was recorded pre and post each application of iontophoresis and 24 
measured using an automated monitor (Minimon 7137 Plus, Kontron 25 
Instruments, UK). All participants rested for 20 minutes in a supine position to 26 
allow skin temperature and skin blood flow to stabilise before application of 27 
iontophoresis.  28 
 29 
Iontophoresis was applied to the left side of the body to the volar aspect of the 30 
forearm, non-glabrous region of the middle finger, non-glabrous region of the 31 
Great toe, glabrous region of the middle finger pad and the glabrous region of 32 
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the Great toe pad. The order of sites tested was balanced. Each skin site was 1 
cleaned with deionised water prior to iontophoresis. 2 
 3 
In preliminary studies we observed that iontophoresis was difficult to conduct on 4 
AFD as it appeared that they had greater skin resistance which limited the 5 
current that could be applied. Approximately 25 μA could be consistently 6 
delivered to both AFD and CAU participants. We therefore adapted our protocol 7 
based on previous investigations using intermittent pulses of similar duration 8 
(Morris and Shore 1996; Hendry and Marshall 2004; Easter and Marshall 2005).  9 
 10 
Iontophoresis was performed using both an anode and cathode connected to a 11 
battery powered iontophoresis controller (MIC2, Moor Instruments, UK). The 12 
iontophoresis chamber, which is a small Perspex ring (MIC-ION1R-P1, Moor 13 
Instruments, UK) with an inner diameter of 8 mm, was filled with approximately 14 
0.2 mL of the relevant drug solution. A laser Doppler probe (VP1T / 7, Moor 15 
Instruments, UK), utilised to measure skin temperature and skin blood flow, was 16 
placed into the Perspex ring and connected to a laser Doppler flowmetry 17 
monitor (moorVMS-LDF, Moor Instruments, UK). Laser Doppler and 18 
iontophoresis data were recorded using a data acquisition system and software 19 
(Powerlab and LabChart 7, AD Instruments, New Zealand). 20 
 21 
Protocols 22 
 Acetylcholine (ACh) 23 
 24 
ACh was used at the anode with the cathode placed proximally to the site of 25 
interest. The protocol consisted of six pulses of 25 μA followed by one pulse of 26 
50 μA and one of 100 μA for 20 seconds all separated by 60 second intervals in 27 
which no current was applied. After an interval of five minutes the protocol was 28 
repeated on the next skin site. 29 
 30 
 Sodium nitroprusside (SNP) 31 
 32 
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SNP was used at the cathode with the anode placed proximally to the site of 1 
interest. The protocol consisted of six pulses of 25 μA followed by one pulse of 2 
50 μA and one of 100 μA for 20 seconds all separated by 120 second intervals 3 
in which no current was applied as the dilator response to SNP takes longer to 4 
develop than ACh (Ramsay et al. 2002; Hendry and Marshall 2004). After an 5 
interval of five minutes the protocol was repeated on the next skin site. 6 
 7 
 Noradrenaline (NA) 8 
 9 
NA was used at the anode with the cathode placed proximally to the site of 10 
interest. The protocol consisted of six pulses of 25 μA followed by one pulse of 11 
50 μA and one of 100 μA for 30 seconds all separated by 60 second intervals in 12 
which no current was applied. After an interval of five minutes the protocol was 13 
repeated on the next skin site. 14 
 15 
Drugs 16 
 17 
ACh was obtained as Miochol-E (Bausch & Lomb, Surrey, UK) and prepared 18 
immediately prior to use to a concentration of 1 w/v %. SNP (Rottapharm 19 
Madaus, Barcelona, Spain) was dissolved into water for injection to a 20 
concentration of 0.01 w/v %. NA (Hospira, Leamington Spa, UK) was diluted 21 
into water for injection to a concentration of 0.5 mM. As SNP and NA are 22 
photosensitive, all solutions were wrapped in foil and stored in the dark prior to 23 
use, with stock solutions being used within eight hours. 24 
 25 
Pilot studies using the vehicle for each drug on the skin sites used for the main 26 
protocol showed that the only skin site to show an increase in skin blood flow 27 
was the forearm when the cathode was used (for SNP only); this is addressed 28 
within the discussion section. 29 
 30 
Data analyses 31 
 32 
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Due to high skin resistance it was not possible to deliver all of the current pulses 1 
in each skin site for all participants; this occurred more in the AFD participants. 2 
As a consequence the number of participants contributing to the mean data 3 
decreased as the cumulative current increased (see Fig. 1 and 2). Participants 4 
who were able to receive the iontophoresis charge were included in the data 5 
analysis. Analysis of the skin blood flow data showed the results were similar if 6 
only those who completed the protocol were included compared to inclusion of 7 
all participants until they were not able to receive the desired current. Therefore, 8 
as we wanted to include as many participants as possible in the analysis we 9 
included all participants until they were not able to receive the desired current. 10 
As blood pressure remained constant throughout the study (see Table 1), skin 11 
blood flow is expressed in laser Doppler units rather than cutaneous vascular 12 
conductance (flux/mean arterial pressure). Responses evoked in the cutaneous 13 
circulation by iontophoresis were expressed as percentage change from that 14 
prior to iontophoresis in the resting condition (averaged over 20 seconds and 15 
set at 0 %). For responses to ACh, average skin blood flow was calculated over 16 
the final 20 seconds of the interval between successive pulses and between 40 17 
to 60 seconds after the final pulse. For SNP, average skin blood flow was 18 
calculated over the final 30 seconds of the interval between successive pulses 19 
and at 90 to 120 seconds after the final pulse. Responses to NA are shorter-20 
lasting (Hendry and Marshall 2004) therefore the minimum skin blood flow was 21 
identified between each pulse and between 0 to 60 seconds after the final 22 
pulse.  23 
 24 
Statistical analyses were conducted using IBM SPSS for Windows version 20 25 
(IBM SPSS Statistics, USA). An α value of 0.05 was used to determine 26 
statistical significance. An independent samples t-test was utilised to compare 27 
participant characteristics and blood pressures between ethnic groups. A paired 28 
samples t-test was utilised to assess within-group change in blood pressure 29 
from pre to post iontophoresis. The skin blood flow data were not normally 30 
distributed therefore group comparisons were conducted utilising a Mann-31 
Whitney U test. Half-maximal effective dose (ED50) expressed as 95 % 32 
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confidence intervals was calculated using GraphPad (Version 5, USA). Maximal 1 
skin blood flow (for ACh and SNP) and minimum skin blood flow (for NA) was 2 
calculated for each participant and compared between ethnic groups. The point 3 
at which the skin blood flow was at a maximum or minimum point was not 4 
always identified following the final pulse, therefore maximum skin blood flow 5 
was taken from wherever it was highest and minimum skin blood flow was taken 6 
from whenever it was lowest. Parametric data in text are presented as mean 7 
(SD). Non-parametric data are presented as median (interquartile range - IQR). 8 
Data displayed in figures are presented as mean (SD). Effect sizes, where 9 
appropriate, were calculated using Cohen’s d for parametric data (denoted by d 10 
in text) and Rosenthal’s r for non-parametric data (denoted by r in text). 11 
 12 
RESULTS 13 
 14 
Both ethnic groups were of similar age (CAU: 21[3] years, AFD: 21[2] years), 15 
height (CAU: 1.8[0.1] m, AFD: 1.8[0.1] m) and mass (CAU: 73.4[10.7] kg, AFD: 16 
73.6[12.2] kg). Blood pressure did not differ between ethnic groups prior to 17 
iontophoresis at each skin site (average over 5 recordings) for ACh, SNP and 18 
NA (Table 1). Blood pressure did not differ between ethnic groups post 19 
iontophoresis, or within group’s pre to post iontophoresis. 20 
 21 
[Insert Table 1 here] 22 
 23 
Prior to iontophoresis local skin blood flow (Table 2) and skin temperature 24 
(Table 3) did not differ between ethnic groups at any skin site except that AFD 25 
had a lower resting skin blood flow at the glabrous toe compared to CAU prior 26 
to SNP application (P = 0.014) however this did not translate to a difference in 27 
skin temperature (Table 3). As expected, resting skin blood flow was higher in 28 
the glabrous skin regions compared to the non-glabrous regions and this was 29 
more marked in the fingers (Table 2). Not all participants could receive the first 30 
pulse of iontophoresis due to high skin resistance; therefore only those who 31 
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successfully received the first pulse were included in the analyses (Tables 2 1 
and 3). 2 
 3 
[Insert Table 2 here] 4 
 5 
[Insert Table 3 here] 6 
 7 
Skin blood flow responses to acetylcholine (ACh) 8 
 9 
Dose response curves to ACh were achieved in the non-glabrous regions 10 
(finger, toe and forearm; Fig. 1a, 1c and 1e respectively) but not the glabrous 11 
regions (finger and toe pads) where the skin blood flow response remained 12 
unchanged (Fig. 1b and 1d respectively). In the non-glabrous finger, AFD 13 
demonstrated less vasodilatation for a given current (Fig. 1a, P = 0.043 - 0.014, 14 
r = 0.48 - 0.52), a lower maximum vasodilatation (Mdn [IQR], AFD n = 11, 15 
41[234] %, CAU n = 12, 351[451] %, P = 0.011, r = 0.53) and a greater ED50 16 
(95% confidence intervals, AFD = 136 μA – 223 μA, CAU = 40 μA – 117 μA, P 17 
< 0.001) compared with CAU. In the non-glabrous toe, again AFD demonstrated 18 
less vasodilatation for a given current (Fig. 1c, P = 0.024 - 0.023, r = 0.50 - 19 
0.68) and a lower maximum vasodilatation (Mdn [IQR], AFD n = 9, 116[318] %, 20 
CAU n = 12, 484[720] %, P = 0.018, r = 0.51) compared with CAU, however 21 
ED50 was similar. There were no skin blood flow differences between groups 22 
for the forearm (Fig. 1e). 23 
 24 
[Insert Fig. 1 here] 25 
  26 
Skin blood flow responses to sodium nitroprusside (SNP) 27 
 28 
Dose response curves to SNP were observed in the forearm skin site for both 29 
groups (Fig. 2e). Dose response curves were also obtained for the non-30 
glabrous finger and toe for CAU but not AFD (Fig. 2a and 2c). No dose 31 
response curves were achieved in the glabrous sites (finger and toe) for CAU or 32 
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AFD (Fig. 2b and 2d). In the forearm skin site AFD demonstrated less 1 
vasodilatation for a given current (Fig. 2e, P = 0.027 - 0.004, r = 0.46 - 0.58) 2 
and a greater ED50 (95% confidence intervals, AFD = 130 μA – 167 μA, CAU = 3 
80 μA – 107 μA, P < 0.001) compared with CAU. Following the final pulse on 4 
the glabrous toe skin site AFD had a smaller skin blood flow response 5 
compared with CAU (P = 0.018, r = 0.61).  6 
 7 
[Insert Fig. 2 here] 8 
 9 
Skin blood flow responses to noradrenaline (NA) 10 
 11 
Vasoconstriction in response to NA was achieved in the forearm, non-glabrous 12 
finger and glabrous toe. Vasoconstriction was also achieved in the glabrous 13 
finger and non-glabrous toe of AFD but not CAU; however there were no skin 14 
blood flow differences at any skin site between ethnic groups. There were no 15 
ethnic differences for minimum skin blood flow for any skin site (Table 4). 16 
 17 
[Insert Table 4 here] 18 
  19 
The responses to transdermal delivery of ACh, SNP and NA to the various skin 20 
regions in the two ethnic groups are summarised in Table 5. 21 
 22 
[Insert Table 5 here] 23 
 24 
DISCUSSION 25 
  26 
In the present study, comparing young male CAU and AFD participants, we 27 
observed a lower increase in skin blood flow for a given current in response to 28 
ACh in the non-glabrous finger and non-glabrous toe in AFD (Fig. 1a and 1c, 29 
respectively); however these differences were not repeated with SNP (Fig. 2). 30 
Furthermore, there were no differences between ethnic groups in response to 31 
NA at any skin site. These findings allow us to partly accept our hypothesis 32 
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regarding ACh and SNP whilst we reject our hypothesis for NA. This is in 1 
contrast to other studies which have investigated whole arm or systemic 2 
responses between ethnic groups (Jones et al. 1999; Cardillo et al. 1999; 3 
Rosenbaum et al. 2002). We observed a lower endothelium-dependent 4 
vasodilatation (Fig. 1) in AFD than CAU in the non-glabrous finger and non-5 
glabrous toe skin sites although responses at the forearm did not differ between 6 
groups. The non-glabrous toe skin blood flow responses for CAU displays an 7 
initial increase in skin blood flow, followed by a decrease and a subsequent 8 
increase. Looking at the individual data it appears that this pattern is primarily 9 
driven by two CAU who had an early exaggerated response to ACh where as all 10 
other CAU demonstrated a linear increase in skin blood flow. We are unsure 11 
why two CAU demonstrated such an early exaggerated response to ACh. 12 
Although we observed a significantly lower skin blood flow response in the non-13 
glabrous toe skin site between CAU and AFD following the final pulse, only 14 
three AFD were remaining at that data point thus caution should be exercised 15 
when considering this time point. 16 
 17 
Our results from the forearm skin site, displaying similar skin blood flow 18 
responses, appear to support some previous findings (Kahn et al. 2002) but not 19 
all (Jones et al. 1999; Cardillo et al. 1999). In the present study, whilst the 20 
forearm microcirculation appears to respond similarly in CAU and AFD to 21 
iontophoresis of ACh, it seems that the control of the microcirculation of the 22 
fingers and toes in the non-glabrous skin sites differs between CAU and AFD; 23 
this may play a role in the increased susceptibility of AFD to cold injuries. 24 
 25 
The present study supports the findings that a difference exists in response to 26 
SNP at the forearm (Stein et al. 1997; Cardillo et al. 1998; Cardillo et al. 1999; 27 
Gainer et al. 2001; Rosenbaum et al. 2002). Reduced vasodilatation in AFD 28 
compared with CAU in response to SNP would suggest an altered function at 29 
the vascular smooth muscle cells. However, an electric-induced hyperaemic 30 
response (galvanic response) is prominent at the cathode site where SNP is 31 
used (Morris and Shore 1996). The increase in skin blood flow observed upon 32 
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electrical stimulation has been shown to recruit mechano-insensitive C-units 1 
(Schmelz et al. 2000) which release vasodilators calcitonin gene related peptide 2 
with smaller contributions from substance P (Sauerstein et al. 2000). We 3 
attempted to attenuate this response by using a low current (i.e. 25 μA) in short 4 
durations (i.e. 20 seconds). During pilot testing we observed an increase in skin 5 
blood flow (~2100 % increase from rest following the final pulse, n = 5) in the 6 
forearm when water for injection was used at the cathode whereas the other 7 
skin sites did not demonstrate any significant increase in skin blood flow. This is 8 
therefore a limitation of the iontophoresis technique in that the responses to 9 
iontophoresis of SNP in the forearm circulation may, in part, be influenced by a 10 
sensory component / galvanic response (Morris and Shore 1996), but the 11 
responses to SNP in other skin sites appear to be nitric oxide driven. 12 
Responses to SNP at other sites did not differ between groups except following 13 
the final pulse on the glabrous toe (Fig. 2d). We are unsure why this difference 14 
between groups occurred but feel that we cannot comment on the possible 15 
physiological implications of this due to the low number of participants 16 
remaining in the AFD group (n = 3) at this time / current application. 17 
 18 
It was expected that NA would cause a greater decrease in skin blood flow in 19 
AFD compared with CAU; this was not the case in the present study. Previous 20 
research has showed that CAU and AFD do not appear to differ in response to 21 
intra-arterial infusion of angiotensin II (Jones et al. 1999); others have shown 22 
that intra-arterial infusion of phenylephrine causes a greater vasoconstrictor 23 
response in AFD than CAU (Stein et al. 2000). Both vasoactive agents appear 24 
to exert their vasoconstrictor effects by modulating intracellular calcium levels 25 
but the reason for the discrepancy between studies may be due to different 26 
mechanism of action; angiotensin II acts on the endothelium as well as the 27 
smooth muscle cell, whereas phenylephrine, an α1 receptor agonist, acts upon 28 
the smooth muscle cell (Pueyo and Michel 1997; Rang et al. 2012). NA is able 29 
to activate α (vasoconstrictor) as well as β (vasodilatory) adrenergic receptors 30 
(Bylund et al. 1994; Rang et al. 2012) which may mask an increased sensitivity 31 
in α receptors in AFD as previously reported (Stein et al. 2000). Human 32 
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vascular smooth muscle contains several types of α receptors with the α2C 1 
subtype appearing to become active under conditions such as skin cooling 2 
(Chotani et al. 2004). In support of this, previous studies have shown 3 
vasoconstriction responses to local cooling is governed primarily by α2 4 
receptors (Ekenvall et al. 1988), more specifically α2C subtype (Chotani et al. 5 
2000). These specific receptors are translocated from the Golgi to the vascular 6 
smooth muscle cell surface facilitated by Rho kinase (Bailey et al. 2004; Honda 7 
et al. 2007). During forearm skin cooling, cutaneous vascular conductance is 8 
significantly attenuated following Rho kinase inhibition which may be as a result 9 
of a reduced translocation of α2C receptors to the vascular smooth muscle cell 10 
surface (Thompson-Torgerson et al. 2007). We previously observed a lower 11 
skin blood flow in AFD during hand cooling compared with CAU (Maley et al. 12 
2014); whether there are ethnic differences in α2C receptor subtype is not 13 
known. 14 
 15 
Whilst the present study provides evidence of an attenuated response to ACh in 16 
AFD, the precise mechanism(s) controlling this response is not known. ACh 17 
binds to muscarinic receptors on the endothelial surface and produces 18 
mediators to effect vasodilatation (Furchgott 1983; Komori and Suzuki 1987; 19 
Shore 1996; Shibasaki et al. 2002). These mediators include prostanoids, 20 
produced by the cyclooxygenase (COX) enzyme, which are subsequently 21 
metabolised to various prostaglandins, including prostacyclin, a known 22 
vasodilator (Duffy et al. 1998; Parkington et al. 2004; Félétou 2011). Previous 23 
investigations have demonstrated that responses to ACh in the forearm 24 
circulation are predominantly mediated through prostanoid-dependent 25 
pathways, and an attenuated vasodilatation is observed in the forearm 26 
circulation with COX inhibition compared with a control (Noon et al. 1998; 27 
Holowatz et al. 2005). However, there are further increases in non-glabrous 28 
finger skin blood flow in response to ACh when COX is inhibited in young 29 
healthy males (Hendry and Marshall 2004). Thus, it appears that there may be 30 
a greater contribution of prostanoid vasoconstrictor products in the finger 31 
compared with the forearm. From this, it may be that the balance between 32 
17 
 
vasoconstrictor and vasodilator COX products may differ between groups. Even 1 
though responses to SNP, a nitric oxide donor, is similar between groups this 2 
does not rule out possible differences in nitric oxide bioavailability affecting ACh 3 
induced vasodilatation. Evidence of a reduced nitric oxide bioavailability in AFD 4 
compared with CAU has been previously reported and is attributable to an 5 
increased superoxide production (Kalinowski et al. 2004; Mata-Greenwood and 6 
Chen 2008; Feairheller et al. 2011); this type of oxidative stress and diminished 7 
nitric oxide bioavailability has been attributed to vascular disorders such as 8 
hypertension (Griendling and FitzGerald 2003) as well as a reduced nitric oxide-9 
dependent vasodilatation in aged skin (Holowatz and Kenney 2010). 10 
 11 
Although the present study examined skin blood flow responses to vasoactive 12 
agents in individuals at rest at environmental temperature of 23 °C to 24 °C, we 13 
have previously reported that AFD experience an attenuated vasodilatation 14 
compared with CAU during rewarming following hand cooling (Maley et al. 15 
2014). Low perfusion of tissue during exposure to cold and upon rewarming can 16 
be a factor leading to environmental injuries such as NFCI (Endrich et al. 1982; 17 
Jia and Pollock 1997; Jia and Pollock 1998). From the present study, as NA 18 
responses were similar between ethnic groups it is suggested that the skin 19 
blood flow differences observed during the previous study may, in part, be due 20 
to differences in the reactivity of the endothelium in AFD compared with CAU 21 
which may help explain why this group is more susceptible to freezing and non-22 
freezing cold injuries. The precise mechanism underpinning differences in 23 
rewarming times following local cold exposure between AFD and CAU such as 24 
that seen previously (Maley et al., 2014) has not yet been fully elucidated. Clues 25 
come from findings such as those of Hope et al. (2014) who reported that the 26 
nitric oxide donor glyceryl trinitrate improves rewarming times following foot 27 
cooling in individuals with cold sensitivity (sub-clinical NFCI). However, we did 28 
not observe any differences in skin temperature between uninjured AFD and 29 
CAU to the same foot cooling protocol (Maley et al. 2014) therefore, in support 30 
of the present study, the role of nitric oxide in CAU and AFD appears similar in 31 
response to short duration (2 minute) foot cooling and subsequent rewarming. 32 
18 
 
 1 
It is concluded that young healthy AFD have an attenuated endothelium-2 
dependent vasodilatation, compared with CAU, in non-glabrous sites of the 3 
fingers and toes. This may help explain why AFD are more susceptible to cold 4 
injuries which occur predominantly in the peripheries. 5 
 6 
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 1 
Fig. 1 Mean (SD) skin blood flow responses to iontophoresis of acetylcholine in 2 
the non-glabrous finger (a), glabrous finger (b), non-glabrous toe (c) and 3 
glabrous toe (d) and forearm (e). n = 12, unless stated. *Significant difference 4 
between CAU and AFD, P < 0.05. Note scale change for Fig 1e. 5 
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 1 
Fig. 2 Mean (SD) skin blood flow responses to iontophoresis of sodium 2 
nitroprusside in the non-glabrous finger (a), glabrous finger (b), non-glabrous 3 
toe (c) and glabrous toe (d) and forearm (e). n = 12, unless stated. *Significant 4 
difference between CAU and AFD, P < 0.05. Note scale change for Fig 2e. 5 
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Table 1 Mean (SD) blood pressure prior to iontophoresis (n = 24) 1 
 Blood Pressure (mmHg) 
 Acetylcholine Sodium nitroprusside Noradrenaline 
Variable CAU AFD CAU AFD CAU AFD 
Systolic 120(11) 121(9) 119(9) 124(9) 120(7) 123(9) 
Diastolic 60(6) 64(8) 62(5) 65(8) 62(7) 63(5) 
MAP 80(6) 83(8) 81(5) 85(8) 81(6) 83(6) 
MAP = Mean Arterial Pressure. 2 
 3 
 4 
  5 
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Table 2 Median (IQR) local skin blood flow (laser Doppler units) prior to 1 
iontophoresis at each skin site 2 
 Laser Doppler Units 
 Acetylcholine Sodium nitroprusside Noradrenaline 
Site CAU AFD CAU AFD CAU AFD 
Forearm 15(10) 
n=12 
18(16) 
n=11 
16(8) 
n=12 
15(6) 
n=11 
17(17) 
n=11 
11(14) 
n=11 
NGF 58(24) 
n=12 
53(21) 
n=11 
61(31) 
n=12 
36(117) 
n=8 
55(35) 
n=12 
59(102) 
n=11 
GF 399(182) 
n=11 
326(370) 
n=9 
341(249) 
n=12 
255(293) 
n=12 
247(283) 
n=11 
122(462) 
n=11 
NGT 18(37) 
n=12 
11(34) 
n=9 
20(22) 
n=12 
11(8) 
n=12 
11 (27) 
n=12 
16(18) 
n=11 
GT 38(124) 
n=12 
13(53) 
n=8 
44(61)* 
n=12 
15(24) 
n=10 
71(163) 
n=11 
41(94) 
n=9 
*Significant difference between groups (P < 0.05). NGF = Non-glabrous finger, GF = Glabrous 3 
finger, NGT = Non-glabrous toe, GT = Glabrous toe. 4 
 5 
 6 
 7 
  8 
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Table 3 Median (IQR) local skin temperature prior to iontophoresis at each skin 1 
site 2 
 Skin Temperature (°C) 
 Acetylcholine Sodium nitroprusside Noradrenaline 
Site CAU AFD CAU AFD CAU AFD 
Forearm 28.9(1.2) 
n=12 
28.4(1.1) 
n=11 
28.8(0.6) 
n=12 
27.7(1.6) 
n=11 
29.4(1.9) 
n=11 
29.2(1.4) 
n=11 
NGF 29.1(1.9) 
n=12 
28.7(1.2) 
n=11 
29.6(2.7) 
n=12 
27.3(2.0) 
n=8 
30.2(0.8) 
n=12 
29.5(2.4) 
n=11 
GF 29.7(2.0) 
n=11 
30.5(4.8) 
n=9 
30.2(3.6) 
n=12 
28.8(4.8) 
n=12 
30.4(1.9) 
n=11 
30.2(3.3) 
n=11 
NGT 26.6(3.3) 
n=12 
27.1(3.2) 
n=9 
26.6(2.4) 
n=12 
27.0(3.5) 
n=12 
27.6(3.4) 
n=12 
27.6(3.4) 
n=11 
GT 26.3(3.9) 
n=12 
25.5(2.7) 
n=8 
25.4(4.4) 
n=12 
24.3(2.9) 
n=10 
28.2(2.4) 
n=11 
26.9(3.4) 
n=9 
NGF = Non-glabrous finger, GF = Glabrous finger, NGT = Non-glabrous toe, GT = Glabrous toe. 3 
 4 
  5 
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Table 4 Median (IQR) and mean (SD) maximum percentage change in skin 1 
blood flow in response to iontophoresis of noradrenaline 2 
 Ethnicity 
Site CAU AFD 
Forearm ^ -39[15] % 
n = 11 
-29[55] % 
n = 11 
Non-glabrous finger -65[23] % 
n = 12 
-54[25] % 
n = 11 
Glabrous finger -64[21] % 
n = 11 
-65[25] % 
n = 11 
Non-glabrous toe -44[32] % 
n = 12 
-46[27] % 
n = 11 
Glabrous toe -58[27] % 
n = 11 
-46[33] % 
n = 9 
^ Median (IQR). 3 
 4 
 5 
  6 
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Table 5 Summary of skin blood flow results  1 
Group Response to 
Acetylcholine 
Response to Sodium 
nitroprusside 
Response to 
Noradrenaline 
CAU  forearm, NGF, NGT  forearm, NGF, NGT  forearm, NGF, GT 
AFD  forearm, NGF, NGT 
 
 forearm  forearm, NGF, GF, 
NGT, GT 
CAU vs. AFD NGF and NGT 
CAU > AFD 
Forearm  
CAU > AFD 
No differences 
NGF = Non-glabrous finger, GF = Glabrous finger, NGT = Non-glabrous toe, GT = Glabrous toe. 2 
 3 
  4 
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